Although no consistent conclusions were obtained regarding the relationship between genetic variants and visual gain after intravitreal injections of anti-VEGF agents, previous studies demonstrated the relationship between genetic factors and the treatment outcomes, including visual outcome and recurrence after photodynamic therapy (PDT) for exudative AMD in Japanese27, 28, 29. The gene discussed is VEGFA; the disease is age-related macular degeneration.